Shanghai Junshi Biosciences Co., Ltd. Class ASSE: 688180

Announcement on Voluntary Disclosure of the FDA Approval of Clinical Trial Application for JS212

· Issued by Shanghai Junshi Biosciences Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of the FDA Approval of Clinical Trial Application for JS212

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment